New insights into human enteric neuropathies

Neurogastroenterology and Motility

Volumn 16, Issue SUPPL. 1, 2004, Pages 143-147

  De Giorgio, R ^a,b   Guerrini, S ^a   Barbara, G ^a   Cremon, C ^a   Stanghellini, V ^a   Corinaldesi, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Achalasia; Chronic constipation; Chronic intestinal pseudo obstruction; Enteric nervous system; Hirschsprung's disease; Human enteric neuropathies; Neuronal degeneration

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LAXATIVE;

AGANGLIONOSIS; CELL LOSS; CONFERENCE PAPER; CONSTIPATION; DRUG MEGADOSE; ESOPHAGUS ACHALASIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GENETIC ANALYSIS; HIRSCHSPRUNG DISEASE; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; INFLAMMATION; INTESTINE INNERVATION; INTESTINE OBSTRUCTION; IRRITABLE COLON; NERVE DEGENERATION; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 2342540347     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1743-3150.2004.00491.x     Document Type: Conference Paper

References (40)

1. Goyal RK, Hirano I. The enteric nervous system. New Engl J Med 1996; 334: 1106-15.
2. Gershon MD, Kirchgessner AL, Wade PR. Functional anatomy of the enteric nervous system. In: Johnson LR, eds. Physiology of the Gastrointestinal Tract. New York: Raven Press, 1994: 381-422.
3. Furness JB, Costa M. The Enteric Nervous System. Edinburgh-New York: Churchill Livingstone, 1987.
4. Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93: 610-39.
5. De Giorgio R, Stanghellini V, Barbara G, et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000; 35: 114-22.
6. De Giorgio R, Di Simone M, Stanghellini V, et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol 1999; 94: 2357-62.
7. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986; 90: 924-9.
8. Robertson CS, Martin BA, Atkinson M. Varicella-Zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993; 34: 299-302.
9. Singaram C, Sweet MA, Belcaster GM, Hefle SL, Kalloo AN, Pasricha J. A novel autoantibody exists in patients with esophageal achalasia (Abstract). Gastroenterology 1994; 106: A566.
10. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003; 52: 629-36.
11. Tullio-Pelet A, Salomon R, Hadj-Rabia S, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000; 26: 332-5.
12. Vanderwinden J-M, Mailleux P, Schiffmann SN, Vanderhaegen J-J, De Laet M-H. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. New Engl J Med 1992; 327: 511-5.
13. Stanghellini V, Corinaldesi R, Barbara L. Pseudo-obstruction syndromes. Baillierzes Clin Gastroenterol 1988; 2: 225-54.
14. Coulie B, Camilleri M. Intestinal Pseudo-obstruction. Annu Rev Med 1999; 50: 37-55.
15. Hall KE, Wiley JW. Neural injury, repair and adaptation in the GI tract. I. New insights into neuronal injury: a cautionary tale. Am J Physiol 1998; 274: G978-83.
16. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 1985; 18: 255-64.
17. Debinski, HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997; 41: 100-6.
18. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991; 100: 137-42.
19. Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon VA. Paraneoplastic anti-purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Laboratory Invest 1991; 65: 412-20.
20. De Giorgio R, Bovara M, Barbara G, et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003; 125: 70-9.
21. Smith VV, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 1366-71.
22. De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454-9.
23. Newgreen D, Young HM. Enteric nervous system: development and developmental disturbances-part 1. Pediatir Dev Pathol 2002; 5: 224-47.
24. Meier-Ruge W. Hirschsprung's disease: its etiology, pathogenesis and differential diagnosis. In: Grundmann E, Kirsten WH, eds. Current Topics in Pathology. New York: Springer, 1974: 131-79.
25. Camilleri M. Enteric nervous system disorders, genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil 2001; 13: 277-95.
26. Robertson K, Mason I, Hall I. Hirschsprung's disease, genetic mutations in mice and men. Gut 1997; 41: 436-41.
27. Martucciello G, Ceccherini I, Lerone M, Jasonni V. Pathogenesis of Hirschsprung's disease. J Pediatr Surg 2000; 35: 1017-25.
28. Nagaya M, Kato J, Niimi N, Tanaka S, Wakamatsu N. Clinical features of a form of Hirschsprung's disease caused by a novel genetic abnormality. J Pediatr Surg 2002; 37: 1117-22.
29. Sham MH, Lui VC, Fu M, Chen B, Tam PK. SOX10 is abnormally expressed in aganglionic bowel of Hirschsprung's disease infants. Gut 2001; 49: 220-6.
30. Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 1999; 17: 380-93.
31. Romeo G, Ceccherini I, Celli J, et al. Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Int Med 1998; 243: 515-20.
32. Hofstra RM, Wu Y, Stulp RP, et al. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 2000; 15: 418-29.
33. Doray B, Salomon R, Amiel J, et al. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet 1998; 7: 1449-52.
34. Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998; 18: 171-3.
35. Amiel J, Espinosa-Parilla Y, Steffann J, et al. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 2001; 69: 1370-7.
36. Park HJ, Kamm MA, Abbasi AM, Talbot IC. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum 1995; 38: 509-13.
37. Porter AJ, Wattchow DA, Hunter A, Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis 1998; 13: 208-16.
38. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 (Suppl. 1): 41-4.
39. Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972-9.
40. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662-71.